ArticleBMC cancer2026

Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized controlled trial.

Hye-Sol Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.